Literature DB >> 2625377

Diabetic maculopathy in a Jamaican population.

B J Moriarty1, D T Dunn, A P Moriarty.   

Abstract

Maculopathy is the commonest cause of severe visual loss from diabetic retinopathy in Jamaica [5]. Ophthalmic assessment of 158 black Jamaican maturity onset diabetics referred randomly from the primary and secondary health centres, demonstrated maculopathy in 48% of patients. Duration of diabetes was a strong risk factor for maculopathy (p less than 0.001). Poor compliance with diabetic and hypertensive therapy may influence the prevalence of maculopathy.

Entities:  

Mesh:

Year:  1989        PMID: 2625377     DOI: 10.1007/bf02279865

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  9 in total

1.  Macular edema--an overlooked complication of diabetic retinopathy.

Authors:  A Patz; H Schatz; J W Berkow; A M Gittelsohn; U Ticho
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1973 Jan-Feb

2.  Diabetic retinopathy and visual loss in a Jamaican population.

Authors:  B J Moriarty; R W Acheson; G R Serjeant
Journal:  West Indian Med J       Date:  1987-03       Impact factor: 0.171

3.  Clinical profile of diabetes mellitus in Jamaica (phasic insulin dependence).

Authors:  E Y Morrison; R Richards
Journal:  West Indian Med J       Date:  1985-06       Impact factor: 0.171

4.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

5.  Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.

Authors:  R J Olk
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

6.  Diabetic macular edema and argon laser photocoagulation: a prospective randomized study.

Authors:  G W Blankenship
Journal:  Ophthalmology       Date:  1979-01       Impact factor: 12.079

7.  Diabetic maculopathy. A critical review highlighting diffuse macular edema.

Authors:  G H Bresnick
Journal:  Ophthalmology       Date:  1983-11       Impact factor: 12.079

8.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

9.  Xenon arc photocoagulation for the treatment of diabetic maculopathy. Interim report of a multicentre controlled clinical study.

Authors:  C Townsend; J Bailey; E Kohner
Journal:  Br J Ophthalmol       Date:  1980-06       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.